Optimizing treatment selection and sequencing decisions for first-line maintenance therapy of newly diagnosed advanced ovarian cancer

The incidence and mortality rates of ovarian cancer are increasing globally. Ovarian cancer is diagnosed at an advanced stage in 80% of women. After standard, platinum-based, front-line chemotherapy, poly (ADP-ribose) polymerase (PARP) inhibitors and antiangiogenic agents are successfully employed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Goh, Jeffrey C.H., Gourley, Charlie, Tan, David S P, Nogueira-Rodrigues, Angélica, Elghazaly, Hesham, Edy Pierre, Marc, Giornelli, Gonzalo, Kim, Byoung-Gie, Morales–Vasquez, Flavia, Tyulyandina, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263863/
https://www.ncbi.nlm.nih.gov/pubmed/35813356
http://dx.doi.org/10.1016/j.gore.2022.101028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263863/
https://www.ncbi.nlm.nih.gov/pubmed/35813356
http://dx.doi.org/10.1016/j.gore.2022.101028

Ejemplares similares